Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya

Authors: Joyce U Nyiro, Eduard J Sanders, Caroline Ngetsa, Steve Wale, Ken Awuondo, Elizabeth Bukusi, Matthew A Price, Pauli N Amornkul, D James Nokes

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Herpes Simplex Virus type 2 (HSV-2) has public health importance as a leading cause of genital ulcers, a co-factor in HIV-1 acquisition and transmission and as a cause of neonatal herpes infections. Little is known of its epidemiology and burden in Coastal Kenya.

Methods

We screened plasma samples for HSV-2 infection from 826 women aged 15-34 years who participated in an HIV-1 survey in Kilifi in 2004. The sample comprised 563 women selected randomly from a demographic surveillance system (DSS) and 263 women who presented for voluntary counseling and testing (VCT). Predictors for HSV-2 seropositivity were determined using multivariate logistic regression. The incidence of HSV-2 infection and risk of neonatal herpes were estimated by a simple catalytic model fitted to age-seroprevalence data.

Results

HSV-2 prevalence was 32% in the DSS recruits vs. 44% in the VCT recruits (P < 0.001), while, HIV-1 prevalence was 8% in the DSS recruits vs. 12% in the VCT recruits (P = 0.12). Independent risk factors for HSV-2 infection in all women were: older age (30-34 years; odds ratio (OR) 10.5, 95% confidence interval (CI): 5.2 - 21.0), recruitment from VCT (OR 1.5, 95% CI: 1.1 - 2.1), history of genital ulcers (OR 1.7, 95% CI: 1.2 - 2.3) and HIV infection (OR 2.7, 95% CI: 1.6-4.6). Education beyond primary (OR 0.7, 95% CI: 0.5 - 0.9) was inversely associated with HSV-2 infection. In the DSS sample, HSV-2 incidence was estimated at 4 cases (95% CI: 3.3 - 4.4) per 100 women per year, 17 cases (95% CI: 16-18) per 1,000 pregnancies per year and 33 neonatal cases (95% CI: 31-36) per 100,000 births per year.

Conclusions

HSV-2 transmission is rapid following the onset of sexual activity and likely to result in a significant burden of genital ulcer disease. Nevertheless, the burden of neonatal HSV-2 can be predicted to be low. Educating young women about HSV-2 infection may help in reducing its burden in this semi-urban population.
Appendix
Available only for authorised users
Literature
1.
go back to reference Corey L, Handsfield HH: Genital herpes and public health: addressing a global problem. Jama. 2000, 283 (6): 791-794. 10.1001/jama.283.6.791.CrossRefPubMed Corey L, Handsfield HH: Genital herpes and public health: addressing a global problem. Jama. 2000, 283 (6): 791-794. 10.1001/jama.283.6.791.CrossRefPubMed
2.
go back to reference Gupta R, Warren T, Wald A: Genital herpes. Lancet. 2007, 370 (9605): 2127-2137. 10.1016/S0140-6736(07)61908-4.CrossRefPubMed Gupta R, Warren T, Wald A: Genital herpes. Lancet. 2007, 370 (9605): 2127-2137. 10.1016/S0140-6736(07)61908-4.CrossRefPubMed
3.
go back to reference Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L: Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. Jama. 2003, 289 (2): 203-209. 10.1001/jama.289.2.203.CrossRefPubMed Brown ZA, Wald A, Morrow RA, Selke S, Zeh J, Corey L: Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant. Jama. 2003, 289 (2): 203-209. 10.1001/jama.289.2.203.CrossRefPubMed
4.
go back to reference O'Riordan DP, Golden WC, Aucott SW: Herpes simplex virus infections in preterm infants. Pediatrics. 2006, 118 (6): e1612-1620. 10.1542/peds.2005-1228.CrossRefPubMed O'Riordan DP, Golden WC, Aucott SW: Herpes simplex virus infections in preterm infants. Pediatrics. 2006, 118 (6): e1612-1620. 10.1542/peds.2005-1228.CrossRefPubMed
5.
go back to reference Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, Watts DH, Berry S, Herd M, Corey L: The acquisition of herpes simplex virus during pregnancy. The New England journal of medicine. 1997, 337 (8): 509-515. 10.1056/NEJM199708213370801.CrossRefPubMed Brown ZA, Selke S, Zeh J, Kopelman J, Maslow A, Ashley RL, Watts DH, Berry S, Herd M, Corey L: The acquisition of herpes simplex virus during pregnancy. The New England journal of medicine. 1997, 337 (8): 509-515. 10.1056/NEJM199708213370801.CrossRefPubMed
6.
go back to reference Brown ZA, Benedetti J, Ashley R, Burchett S, Selke S, Berry S, Vontver LA, Corey L: Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. The New England journal of medicine. 1991, 324 (18): 1247-1252. 10.1056/NEJM199105023241804.CrossRefPubMed Brown ZA, Benedetti J, Ashley R, Burchett S, Selke S, Berry S, Vontver LA, Corey L: Neonatal herpes simplex virus infection in relation to asymptomatic maternal infection at the time of labor. The New England journal of medicine. 1991, 324 (18): 1247-1252. 10.1056/NEJM199105023241804.CrossRefPubMed
7.
go back to reference Bollen LJ, Whitehead SJ, Mock PA, Leelawiwat W, Asavapiriyanont S, Chalermchockchareonkit A, Vanprapar N, Chotpitayasunondh T, McNicholl JM, Tappero JW, Shaffer N, Chuachoowong R: Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?. Aids. 2008, 22 (10): 1169-1176. 10.1097/QAD.0b013e3282fec42a.CrossRefPubMed Bollen LJ, Whitehead SJ, Mock PA, Leelawiwat W, Asavapiriyanont S, Chalermchockchareonkit A, Vanprapar N, Chotpitayasunondh T, McNicholl JM, Tappero JW, Shaffer N, Chuachoowong R: Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?. Aids. 2008, 22 (10): 1169-1176. 10.1097/QAD.0b013e3282fec42a.CrossRefPubMed
8.
go back to reference Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, Self SG, Corey L: Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PloS one. 2008, 3 (5): e2230-10.1371/journal.pone.0002230.CrossRefPubMedPubMedCentral Abu-Raddad LJ, Magaret AS, Celum C, Wald A, Longini IM, Self SG, Corey L: Genital herpes has played a more important role than any other sexually transmitted infection in driving HIV prevalence in Africa. PloS one. 2008, 3 (5): e2230-10.1371/journal.pone.0002230.CrossRefPubMedPubMedCentral
9.
go back to reference Corey L, Wald A, Celum CL, Quinn TC: The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. Journal of acquired immune deficiency syndromes (1999). 2004, 35 (5): 435-445. 10.1097/00126334-200404150-00001.CrossRef Corey L, Wald A, Celum CL, Quinn TC: The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. Journal of acquired immune deficiency syndromes (1999). 2004, 35 (5): 435-445. 10.1097/00126334-200404150-00001.CrossRef
10.
go back to reference Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L: Risk factors for the sexual transmission of genital herpes. Ann Intern Med. 1992, 116 (3): 197-202.CrossRefPubMed Mertz GJ, Benedetti J, Ashley R, Selke SA, Corey L: Risk factors for the sexual transmission of genital herpes. Ann Intern Med. 1992, 116 (3): 197-202.CrossRefPubMed
11.
go back to reference Schillinger JA, McKinney CM, Garg R, Gwynn RC, White K, Lee F, Blank S, Thorpe L, Frieden T: Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004. Sex Transm Dis. 2008, 35 (6): 599-606. 10.1097/OLQ.0b013e3181666fb1.CrossRefPubMed Schillinger JA, McKinney CM, Garg R, Gwynn RC, White K, Lee F, Blank S, Thorpe L, Frieden T: Seroprevalence of herpes simplex virus type 2 and characteristics associated with undiagnosed infection: New York City, 2004. Sex Transm Dis. 2008, 35 (6): 599-606. 10.1097/OLQ.0b013e3181666fb1.CrossRefPubMed
13.
go back to reference Poeran J, Wildschut H, Gaytant M, Galama J, Steegers E, van der Meijden W: The incidence of neonatal herpes in The Netherlands. J Clin Virol. 2008, 42 (4): 321-325. 10.1016/j.jcv.2008.02.004.CrossRefPubMed Poeran J, Wildschut H, Gaytant M, Galama J, Steegers E, van der Meijden W: The incidence of neonatal herpes in The Netherlands. J Clin Virol. 2008, 42 (4): 321-325. 10.1016/j.jcv.2008.02.004.CrossRefPubMed
14.
go back to reference Mindel A, Taylor J, Tideman RL, Seifert C, Berry G, Wagner K, Page J, Marks C, Trudinger B, Cunningham A: Neonatal herpes prevention: a minor public health problem in some communities. Sex Transm Infect. 2000, 76 (4): 287-291. 10.1136/sti.76.4.287.CrossRefPubMedPubMedCentral Mindel A, Taylor J, Tideman RL, Seifert C, Berry G, Wagner K, Page J, Marks C, Trudinger B, Cunningham A: Neonatal herpes prevention: a minor public health problem in some communities. Sex Transm Infect. 2000, 76 (4): 287-291. 10.1136/sti.76.4.287.CrossRefPubMedPubMedCentral
15.
go back to reference Ades AE, Peckham CS, Dale GE, Best JM, Jeansson S: Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health. 1989, 43 (1): 53-60. 10.1136/jech.43.1.53.CrossRefPubMedPubMedCentral Ades AE, Peckham CS, Dale GE, Best JM, Jeansson S: Prevalence of antibodies to herpes simplex virus types 1 and 2 in pregnant women, and estimated rates of infection. J Epidemiol Community Health. 1989, 43 (1): 53-60. 10.1136/jech.43.1.53.CrossRefPubMedPubMedCentral
16.
go back to reference Mullick S, Watson-Jones D, Beksinska M, Mabey D: Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect. 2005, 81 (4): 294-302. 10.1136/sti.2002.004077.CrossRefPubMedPubMedCentral Mullick S, Watson-Jones D, Beksinska M, Mabey D: Sexually transmitted infections in pregnancy: prevalence, impact on pregnancy outcomes, and approach to treatment in developing countries. Sex Transm Infect. 2005, 81 (4): 294-302. 10.1136/sti.2002.004077.CrossRefPubMedPubMedCentral
17.
go back to reference Weiss HA, Buve A, Robinson NJ, Van Dyck E, Kahindo M, Anagonou S, Musonda R, Zekeng L, Morison L, Carael M, Laga M, Hayes RJ: The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. Aids. 2001, 15 (Suppl 4): S97-108.CrossRefPubMed Weiss HA, Buve A, Robinson NJ, Van Dyck E, Kahindo M, Anagonou S, Musonda R, Zekeng L, Morison L, Carael M, Laga M, Hayes RJ: The epidemiology of HSV-2 infection and its association with HIV infection in four urban African populations. Aids. 2001, 15 (Suppl 4): S97-108.CrossRefPubMed
18.
go back to reference Amornkul Pauli, Vandenhoudt Hilde, Nasokho Peter, Odhiambo Frank, Mwaengo Dufton, Hightower Allen, Buve Anne, Misore Ambrose, Vulule John, Vitek Charles, Glynn Judith, Greenberg Alan, Slutsker Laurence, Kevin M, De C: HIV Prevalence and Associated Risk Factors among Individuals Aged 13-34 Years in Rural Western Kenya. PLoS One. 2009, 4 (7): e6470-10.1371/journal.pone.0006470.CrossRefPubMedPubMedCentral Amornkul Pauli, Vandenhoudt Hilde, Nasokho Peter, Odhiambo Frank, Mwaengo Dufton, Hightower Allen, Buve Anne, Misore Ambrose, Vulule John, Vitek Charles, Glynn Judith, Greenberg Alan, Slutsker Laurence, Kevin M, De C: HIV Prevalence and Associated Risk Factors among Individuals Aged 13-34 Years in Rural Western Kenya. PLoS One. 2009, 4 (7): e6470-10.1371/journal.pone.0006470.CrossRefPubMedPubMedCentral
19.
go back to reference GOK: National AIDS and STI Control Programme, 2007 Kenya AIDS Indicator Survey, Official Report. Official KAIS report. 2009 GOK: National AIDS and STI Control Programme, 2007 Kenya AIDS Indicator Survey, Official Report. Official KAIS report. 2009
20.
go back to reference GOK: Effective management for sustainable economic growth and poverty reduction. Kilifi District Development Plan 2002-2008. Government Printers Nairobi. 2002 GOK: Effective management for sustainable economic growth and poverty reduction. Kilifi District Development Plan 2002-2008. Government Printers Nairobi. 2002
21.
go back to reference Bauni EK, Gatakaa H, Williams TN, Nokes DJ, Tsofa BK, JA S: Abstract. 2007, Perinatal and Neonatal mortality among the Mijikenda Community of Kilifi District, 5th UAPS Ghana, Bauni EK, Gatakaa H, Williams TN, Nokes DJ, Tsofa BK, JA S: Abstract. 2007, Perinatal and Neonatal mortality among the Mijikenda Community of Kilifi District, 5th UAPS Ghana,
22.
go back to reference Papo JK, Bauni EK, Sanders EJ, Brocklehurst P, Jaffe HW: Exploring the condom gap: is supply or demand the limiting factor - condom access and use in an urban and a rural setting in Kilifi district, Kenya. Aids. 2011, 25 (2): 247-255. 10.1097/QAD.0b013e328341b9b8.CrossRefPubMed Papo JK, Bauni EK, Sanders EJ, Brocklehurst P, Jaffe HW: Exploring the condom gap: is supply or demand the limiting factor - condom access and use in an urban and a rural setting in Kilifi district, Kenya. Aids. 2011, 25 (2): 247-255. 10.1097/QAD.0b013e328341b9b8.CrossRefPubMed
23.
go back to reference Diagnostics F: Enzyme-linked immunosorbent assay (ELISA) for the qualitative detection of human IgG class antibodies to HSV-2; For in vitro Diagnostic Use. Package insert, Product Code EL0920G. 2007, Cypress, California, USA Diagnostics F: Enzyme-linked immunosorbent assay (ELISA) for the qualitative detection of human IgG class antibodies to HSV-2; For in vitro Diagnostic Use. Package insert, Product Code EL0920G. 2007, Cypress, California, USA
24.
go back to reference Ashley-Morrow R, Nollkamper J, Robinson NJ, Bishop N, Smith J: Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect. 2004, 10 (6): 530-536. 10.1111/j.1469-0691.2004.00836.x.CrossRefPubMed Ashley-Morrow R, Nollkamper J, Robinson NJ, Bishop N, Smith J: Performance of focus ELISA tests for herpes simplex virus type 1 (HSV-1) and HSV-2 antibodies among women in ten diverse geographical locations. Clin Microbiol Infect. 2004, 10 (6): 530-536. 10.1111/j.1469-0691.2004.00836.x.CrossRefPubMed
25.
go back to reference LeGoff J, Mayaud P, Gresenguet G, Weiss HA, Nzambi K, Frost E, Pepin J, Belec L: Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2. J Clin Microbiol. 2008, 46 (6): 1914-1918. 10.1128/JCM.02332-07.CrossRefPubMedPubMedCentral LeGoff J, Mayaud P, Gresenguet G, Weiss HA, Nzambi K, Frost E, Pepin J, Belec L: Performance of HerpeSelect and Kalon assays in detection of antibodies to herpes simplex virus type 2. J Clin Microbiol. 2008, 46 (6): 1914-1918. 10.1128/JCM.02332-07.CrossRefPubMedPubMedCentral
26.
go back to reference Morrow RA, Friedrich D, Krantz E: Performance of the Focus and Kalon Enzyme-Linked Immunosorbent Assays for Antibodies to Herpes Simplex Virus Type 2 Glycoprotein G in Culture-Documented Cases of Genital Herpes. J Clin Microbiol. 2003, 41 (11): 5212-5214. 10.1128/JCM.41.11.5212-5214.2003.CrossRefPubMedPubMedCentral Morrow RA, Friedrich D, Krantz E: Performance of the Focus and Kalon Enzyme-Linked Immunosorbent Assays for Antibodies to Herpes Simplex Virus Type 2 Glycoprotein G in Culture-Documented Cases of Genital Herpes. J Clin Microbiol. 2003, 41 (11): 5212-5214. 10.1128/JCM.41.11.5212-5214.2003.CrossRefPubMedPubMedCentral
27.
go back to reference Cutts FT, Vynnycky E: Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol. 1999, 28 (6): 1176-1184. 10.1093/ije/28.6.1176.CrossRefPubMed Cutts FT, Vynnycky E: Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol. 1999, 28 (6): 1176-1184. 10.1093/ije/28.6.1176.CrossRefPubMed
28.
go back to reference Corey L, Adams HG, Brown ZA, Holmes KK: Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983, 98 (6): 958-972.CrossRefPubMed Corey L, Adams HG, Brown ZA, Holmes KK: Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med. 1983, 98 (6): 958-972.CrossRefPubMed
29.
go back to reference Watson-Jones D, Weiss HA, Rusizoka M, Baisley K, Mugeye K, Changalucha J, Everett D, Balira R, Knight L, Ross D, Hayes RJ: Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial. J Acquir Immune Defic Syndr. 2007, 46 (5): 631-642. 10.1097/QAI.0b013e31815b2d9c.CrossRefPubMedPubMedCentral Watson-Jones D, Weiss HA, Rusizoka M, Baisley K, Mugeye K, Changalucha J, Everett D, Balira R, Knight L, Ross D, Hayes RJ: Risk factors for herpes simplex virus type 2 and HIV among women at high risk in northwestern Tanzania: preparing for an HSV-2 intervention trial. J Acquir Immune Defic Syndr. 2007, 46 (5): 631-642. 10.1097/QAI.0b013e31815b2d9c.CrossRefPubMedPubMedCentral
30.
go back to reference Kapiga SH, Sam NE, Bang H, Ni Q, Ao TT, Kiwelu I, Chiduo S, Ndibe U, Seage G, Coplan P, Shao J, Rosenberg ZF, Essex M: The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis. 2007, 195 (9): 1260-1269. 10.1086/513566.CrossRefPubMed Kapiga SH, Sam NE, Bang H, Ni Q, Ao TT, Kiwelu I, Chiduo S, Ndibe U, Seage G, Coplan P, Shao J, Rosenberg ZF, Essex M: The role of herpes simplex virus type 2 and other genital infections in the acquisition of HIV-1 among high-risk women in northern Tanzania. J Infect Dis. 2007, 195 (9): 1260-1269. 10.1086/513566.CrossRefPubMed
31.
go back to reference Van de Perre P, Segondy M, Foulongne V, Ouedraogo A, Konate I, Huraux JM, Mayaud P, Nagot N: Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect Dis. 2008, 8 (8): 490-497. 10.1016/S1473-3099(08)70181-6.CrossRefPubMed Van de Perre P, Segondy M, Foulongne V, Ouedraogo A, Konate I, Huraux JM, Mayaud P, Nagot N: Herpes simplex virus and HIV-1: deciphering viral synergy. Lancet Infect Dis. 2008, 8 (8): 490-497. 10.1016/S1473-3099(08)70181-6.CrossRefPubMed
32.
go back to reference Rebbapragada A, Wachihi C, Pettengell C, Sunderji S, Huibner S, Jaoko W, Ball B, Fowke K, Mazzulli T, Plummer FA, Kaul R: Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. Aids. 2007, 21 (5): 589-598. 10.1097/QAD.0b013e328012b896.CrossRefPubMed Rebbapragada A, Wachihi C, Pettengell C, Sunderji S, Huibner S, Jaoko W, Ball B, Fowke K, Mazzulli T, Plummer FA, Kaul R: Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. Aids. 2007, 21 (5): 589-598. 10.1097/QAD.0b013e328012b896.CrossRefPubMed
33.
go back to reference Okuku HS, Sanders EJ, Nyiro J, Ngetsa C, Ohuma E, McClelland R, Price M, Graham S: Factors Associated with Herpes Simplex Virus Type 2 Prevalence and Incidence in a Cohort of High-risk Men and Women in Coastal Kenya. Sex Transm Dis. 2010, (under review) Okuku HS, Sanders EJ, Nyiro J, Ngetsa C, Ohuma E, McClelland R, Price M, Graham S: Factors Associated with Herpes Simplex Virus Type 2 Prevalence and Incidence in a Cohort of High-risk Men and Women in Coastal Kenya. Sex Transm Dis. 2010, (under review)
34.
go back to reference Kebede Y, Dorigo-Zetsma W, Mengistu Y, Mekonnen Y, Schaap A, Wolday D, Sanders EJ, Messele T, Coutinho RA, Dukers NH: Transmission of herpes simplex virus Type 2 among factory workers in Ethiopia. J Infect Dis. 2004, 190 (2): 365-372. 10.1086/422038.CrossRefPubMed Kebede Y, Dorigo-Zetsma W, Mengistu Y, Mekonnen Y, Schaap A, Wolday D, Sanders EJ, Messele T, Coutinho RA, Dukers NH: Transmission of herpes simplex virus Type 2 among factory workers in Ethiopia. J Infect Dis. 2004, 190 (2): 365-372. 10.1086/422038.CrossRefPubMed
35.
go back to reference Tobian AA, Charvat B, Ssempijja V, Kigozi G, Serwadda D, Makumbi F, Iga B, Laeyendecker O, Riedesel M, Oliver A, Chen MZ, Reynolds SJ, Wawer MJ, Gray RH, Quinn TC: Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda. J Infect Dis. 2009, 199 (7): 945-949. 10.1086/597074.CrossRefPubMedPubMedCentral Tobian AA, Charvat B, Ssempijja V, Kigozi G, Serwadda D, Makumbi F, Iga B, Laeyendecker O, Riedesel M, Oliver A, Chen MZ, Reynolds SJ, Wawer MJ, Gray RH, Quinn TC: Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda. J Infect Dis. 2009, 199 (7): 945-949. 10.1086/597074.CrossRefPubMedPubMedCentral
36.
go back to reference Tassiopoulos KK, Seage G, Sam N, Kiwelu I, Shao J, Ao TT, Essex M, Coplan P, Rosenberg Z, Hughes M, Kapiga S: Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania. J Infect Dis. 2007, 195 (4): 493-501. 10.1086/510537.CrossRefPubMed Tassiopoulos KK, Seage G, Sam N, Kiwelu I, Shao J, Ao TT, Essex M, Coplan P, Rosenberg Z, Hughes M, Kapiga S: Predictors of herpes simplex virus type 2 prevalence and incidence among bar and hotel workers in Moshi, Tanzania. J Infect Dis. 2007, 195 (4): 493-501. 10.1086/510537.CrossRefPubMed
37.
go back to reference Brown ZA, Gardella C, Wald A, Morrow RA, Corey L: Genital herpes complicating pregnancy. Obstet Gynecol. 2005, 106 (4): 845-856. 10.1097/01.AOG.0000180779.35572.3a.CrossRefPubMed Brown ZA, Gardella C, Wald A, Morrow RA, Corey L: Genital herpes complicating pregnancy. Obstet Gynecol. 2005, 106 (4): 845-856. 10.1097/01.AOG.0000180779.35572.3a.CrossRefPubMed
38.
go back to reference English M, Muhoro A, Aluda M, Were S, Ross A, Peshu N: Outcome of delivery and cause-specific mortality and severe morbidity in early infancy: a Kenyan District Hospital birth cohort. Am J Trop Med Hyg. 2003, 69 (2): 228-232.PubMed English M, Muhoro A, Aluda M, Were S, Ross A, Peshu N: Outcome of delivery and cause-specific mortality and severe morbidity in early infancy: a Kenyan District Hospital birth cohort. Am J Trop Med Hyg. 2003, 69 (2): 228-232.PubMed
Metadata
Title
Seroprevalence, predictors and estimated incidence of maternal and neonatal Herpes Simplex Virus Type 2 infection in semi-urban women in Kilifi, Kenya
Authors
Joyce U Nyiro
Eduard J Sanders
Caroline Ngetsa
Steve Wale
Ken Awuondo
Elizabeth Bukusi
Matthew A Price
Pauli N Amornkul
D James Nokes
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-155

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.